"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
Descriptor ID |
D011471
|
MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 16 | 2 | 18 |
1996 | 15 | 0 | 15 |
1997 | 11 | 3 | 14 |
1998 | 20 | 2 | 22 |
1999 | 19 | 2 | 21 |
2000 | 23 | 2 | 25 |
2001 | 36 | 2 | 38 |
2002 | 25 | 1 | 26 |
2003 | 44 | 5 | 49 |
2004 | 45 | 5 | 50 |
2005 | 42 | 2 | 44 |
2006 | 42 | 3 | 45 |
2007 | 51 | 3 | 54 |
2008 | 38 | 2 | 40 |
2009 | 45 | 4 | 49 |
2010 | 39 | 6 | 45 |
2011 | 43 | 3 | 46 |
2012 | 29 | 7 | 36 |
2013 | 47 | 2 | 49 |
2014 | 39 | 6 | 45 |
2015 | 52 | 3 | 55 |
2016 | 50 | 4 | 54 |
2017 | 32 | 7 | 39 |
2018 | 26 | 2 | 28 |
2019 | 27 | 2 | 29 |
2020 | 26 | 3 | 29 |
2021 | 21 | 2 | 23 |
2022 | 25 | 1 | 26 |
2023 | 17 | 1 | 18 |
2024 | 14 | 1 | 15 |
2025 | 5 | 1 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
PARP inhibitor response is enhanced in prostate cancer when XRCC1 expression is reduced. NAR Cancer. 2025 Jun; 7(2):zcaf015.
-
Frailty and malnutrition scores in predicting postoperative complications in minimally invasive prostatectomy for malignancy of the prostate. J Robot Surg. 2025 Apr 21; 19(1):166.
-
Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 Apr 08; 22(3):432-438.
-
Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing Radiotherapy. JAMA Netw Open. 2025 Mar 03; 8(3):e250491.
-
Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series. Diagn Cytopathol. 2025 Jun; 53(6):E102-E107.
-
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. Nat Commun. 2025 Feb 19; 16(1):1779.
-
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors. CA Cancer J Clin. 2025 Mar-Apr; 75(2):141-167.
-
Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences. Brachytherapy. 2025 Mar-Apr; 24(2):231-237.
-
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. J Natl Cancer Inst. 2025 Jan 01; 117(1):188-197.
-
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. Nat Commun. 2024 12 30; 15(1):10743.